<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30449" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Transcutaneous Electrical Nerve Stimulation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Teoli</surname>
            <given-names>Dac</given-names>
          </name>
          <aff>University of California, Riverside</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dua</surname>
            <given-names>Anterpreet</given-names>
          </name>
          <aff>Augusta University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>An</surname>
            <given-names>Jason</given-names>
          </name>
          <aff>Riverside Community Hospital/UCRiverside</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dac Teoli declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anterpreet Dua declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jason An declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>3</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30449.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Transcutaneous electrical nerve stimulation (TENS) is a therapeutic modality employing electric current to relieve pain by activating peripheral nerves. The evolution of TENS units alongside technological advancements has led to user-friendly interfaces and enhanced portability, with units now small enough to be carried in a pocket. This activity&#x000a0;discusses the indications, contraindications, and clinical significance of TENS, emphasizing the integral role of the interprofessional team in pain management. Electrodes are strategically placed on the skin and connected to the portable unit via wires, allowing users to customize pulse amplitude, frequency, width/duration, and current patterns. Understanding contraindications, such as pregnancy, epilepsy, and pacemakers, is crucial, yet complications or side effects are minimal when operating within manufacturer parameters. Despite ongoing debates on efficacy, numerous studies highlight positive outcomes in pain management, encouraging the exploration of TENS as an alternative or complementary approach.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications for transcutaneous electrical nerve stimulation.</p></list-item><list-item><p>Determine how transcutaneous electrical nerve stimulation reduces pain.</p></list-item><list-item><p>Determine the contraindications of transcutaneous electrical nerve stimulation.</p></list-item><list-item><p>Develop interprofessional team strategies for improving care coordination and communication to advance the control of pain and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30449&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30449">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30449.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Transcutaneous electrical nerve stimulation, or TENS, is a therapeutic approach employing electric current to activate peripheral nerves for pain relief.&#x000a0;The TENS unit, a compact, often battery-powered device, can easily fit into a pocket (see <bold>Image.&#x000a0;</bold>Transcutaneous Electrical Nerve Stimulator). Electrodes are applied to the skin around the targeted region and connected to the TENS unit via wires. Users can then adjust the pulse amplitude, frequency, duration, and pattern of the currents. Thus, high user tolerance is achieved with minimal side effects and no potential for overdose.<xref ref-type="bibr" rid="article-30449.r1">[1]</xref><xref ref-type="bibr" rid="article-30449.r2">[2]</xref>&#x000a0;Low frequencies (&#x0003c;10 Hz) and high intensity induce muscle contractions, while high frequencies (&#x0003e;50 Hz) with low intensity produce paresthesia without contractions.<xref ref-type="bibr" rid="article-30449.r3">[3]</xref>&#x000a0;</p>
        <p>The historical debate over TENS efficacy persists despite proven clinical benefits. Disagreements persist regarding the appropriateness of TENS for specific pain syndromes and conditions. TENS has a rich history dating back to around 60 A.D. when Roman physician Scribonius Largus proposed using an "electric fish" for relief. Electric eels were also historically utilized for pain management benefits. By the 18th century, various devices aimed to treat multiple conditions with electrostatic exposures. A device for clinical therapy using electricity called the "Electreat" was introduced in the 19th century, but its use was&#x000a0;discontinued due to limitations.</p>
        <p>The modern concept of TENS is credited to American neurosurgeon Dr. C. Norman Shealy. His training at Duke University and additional experience at Barnes-Jewish Hospital and Massachusetts General Hospital led to the development of today's TENS units. Dr. Shealy aimed to create an impactful therapy for migraines, back pain, and gout. As the study of TENS advanced, new techniques emerged, including intense TENS, acupuncture TENS, and conventional TENS.<xref ref-type="bibr" rid="article-30449.r4">[4]</xref></p>
        <p>While the medical community engages in an ongoing debate about the efficacy of TENS, a&#x000a0;clearer picture is likely to form as more trials emerge with optimal dosing and specific outcome measures. Despite the controversy and confusion surrounding TENS, numerous studies point towards positive outcomes in pain management. Acknowledging contraindications is crucial, yet the risk of complications or side effects is minimal when TENS is&#x000a0;operated within manufacturer parameters. For those willing to explore alternative avenues, the fusion of TENS with pharmacotherapy holds promise.</p>
      </sec>
      <sec id="article-30449.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>TENS works through several peripheral and central mechanisms to reduce hyperalgesia. At the peripheral level, TENS activates either large-diameter, low-threshold, non-noxious afferents (A-&#x003b2;) or small-diameter, high-threshold peripheral afferents (A-&#x003b4;) to unlock the cascade of postulated mechanisms. This targeted stimulation reduces pain by mitigating nociceptor activity and curtailing unwanted sensations.<xref ref-type="bibr" rid="article-30449.r5">[5]</xref><xref ref-type="bibr" rid="article-30449.r6">[6]</xref>&#x000a0;Molecular studies indicate that the activity and expression of key pain-related ion channels, including voltage-gated sodium channels&#x000a0;in the peripheral nerves, are modulated by TENS, inhibiting nociceptors' neurotransmission.<xref ref-type="bibr" rid="article-30449.r7">[7]</xref></p>
        <p>Afferent input leads to the activation of descending inhibitory pathways within the periaqueductal gray (PAG) area, rostral ventromedial medulla (RVM), and spinal cord. TENS curbs the activity in the Rexed laminae I to V of the dorsal horn.<xref ref-type="bibr" rid="article-30449.r7">[7]</xref>&#x000a0;Communication with these areas occurs with different neurotransmitters and receptors. Concentrations of &#x003b2;-endorphins and methionine-enkephalin, which both interact with opioid receptors, have been shown to increase after high-frequency TENS. Activation of opioid receptors reduces glutamate and substance P release in the spinal cord, thus reducing excitability and potentially decreasing the risk of central sensitization. GABA-A and muscarinic receptors for high-frequency TENS are implicated in mediating CNS effects. Low-frequency TENS utilizes all these receptors in the CNS in addition to serotonin.<xref ref-type="bibr" rid="article-30449.r8">[8]</xref></p>
        <p>Differences in TENS frequency used during treatment are important considerations as they affect which receptor mediates the analgesic effects. Specifically, low-frequency treatment is mediated by the &#x003bc;-receptor, and the &#x003b4;-opioid receptor mediates high-frequency treatment. This is&#x000a0;relevant&#x000a0;for patients using opioid medications for pain relief as the efficacy of low-frequency treatment may be blunted in this population.<xref ref-type="bibr" rid="article-30449.r9">[9]</xref>&#x000a0;</p>
        <p>Peripheral mechanisms are also crucial to the efficacy of TENS. Interestingly, blockage of peripheral &#x003b1;-2A adrenergic receptors, not central &#x003b1;-receptors, prevents TENS analgesia.<xref ref-type="bibr" rid="article-30449.r8">[8]</xref>&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-30449.s4" sec-type="Indications">
        <title>Indications</title>
        <p>TENS has been used for the following conditions.</p>
        <list list-type="bullet">
          <list-item>
            <p>Postoperative pain</p>
          </list-item>
          <list-item>
            <p>Acute non-postoperative pain</p>
          </list-item>
          <list-item>
            <p>Low back pain</p>
          </list-item>
          <list-item>
            <p>Osteoarthritis pain</p>
          </list-item>
          <list-item>
            <p>Diabetic peripheral neuropathy</p>
          </list-item>
          <list-item>
            <p>Fibromyalgia</p>
          </list-item>
          <list-item>
            <p>Neuropathic pain, eg, spinal cord injury&#x000a0;<xref ref-type="bibr" rid="article-30449.r10">[10]</xref></p>
          </list-item>
        </list>
        <p>Its versatility makes TENS a formidable ally in pain management, catering to acute and chronic cases. However, a schism within the scientific community persists regarding its efficacy for specific pain types or conditions fueled by methodological concerns.<xref ref-type="bibr" rid="article-30449.r11">[11]</xref>&#x000a0;This is due to the lack of high-quality studies or disagreement between existing high-quality studies.<xref ref-type="bibr" rid="article-30449.r10">[10]</xref>&#x000a0;</p>
        <p>Three distinct kinds of TENS emerge, each with its conceptual indications:</p>
        <list list-type="order">
          <list-item>
            <p>Intense TENS:<bold>&#x000a0;</bold>Functioning as a "counter-irritant," this type zeroes in on small-diameter, high-threshold cutaneous afferents (A-&#x003b4;), deploying high frequencies and intensities for brief intervals.<xref ref-type="bibr" rid="article-30449.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Acupuncture-like TENS (AL-TENS):<bold>&#x000a0;</bold>Geared for hyperstimulation, AL-TENS steps in for patients unresponsive to conventional TENS. It employs titration to low frequency, higher intensity, and extended pulse width, targeting small-diameter, high-threshold peripheral afferents (A-&#x003b4;).<xref ref-type="bibr" rid="article-30449.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Conventional TENS:<bold>&#x000a0;</bold>This high-frequency, low-intensity, and&#x000a0;short pulse&#x000a0;duration approach selectively stimulates&#x000a0;large-diameter, low-threshold, non-noxious afferents (A-&#x003b2;). This variation finds its niche in treating dermatomal pain distributions.</p>
          </list-item>
        </list>
        <p>Literature evaluating the use of these different modalities in various kinds of pain (eg, acute, non-postoperative, chronic, etc) demonstrates that TENS is effective at treating various types of pain. Often, there was no significant difference in the amount of analgesia between modalities, with some&#x000a0;exceptions for specific pathologies such as rheumatoid arthritis.<xref ref-type="bibr" rid="article-30449.r10">[10]</xref></p>
        <p>Although high-frequency TENS has shown to be more beneficial than low-frequency TENS, the number of high-quality RCTs are insufficient to recommend the application of TENS for chronic pelvic pain or dysmenorrhea.<xref ref-type="bibr" rid="article-30449.r13">[13]</xref></p>
        <p>Affecting 10% to 24% of the general population, chronic neck pain has not been overtly responsive to TENS therapy.<xref ref-type="bibr" rid="article-30449.r14">[14]</xref></p>
      </sec>
      <sec id="article-30449.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Correctly administering TENS demands understanding&#x000a0;its contraindications.&#x000a0;Contraindications&#x000a0;include pregnancy, epilepsy, and the presence of a pacemaker.<xref ref-type="bibr" rid="article-30449.r6">[6]</xref>&#x000a0;However, TENS use is possible in these patient populations if not applied to the abdomen, head, or chest.<xref ref-type="bibr" rid="article-30449.r2">[2]</xref>&#x000a0;Precision in electrode pad placement is paramount, and users must avoid areas prone to skin irritation.<xref ref-type="bibr" rid="article-30449.r15">[15]</xref>&#x000a0;Electrodes should not be placed over active, treatable tumors or close to transdermal drug delivery systems.<xref ref-type="bibr" rid="article-30449.r2">[2]</xref></p>
      </sec>
      <sec id="article-30449.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>The manufacturer's instruction booklet should be consulted before TENS equipment use. Today's TENS units, compact and lightweight, offer a seamless integration into daily life. However, caution dictates that sessions exclude operating heavy machinery, driving, or aquatic endeavors. Electrode pad placement, adept power management, and precise setting titration are pillars for practical TENS application.<xref ref-type="bibr" rid="article-30449.r11">[11]</xref>&#x000a0;Pads are generally placed on relevant dermatomes, but there are a few scenarios where this is contraindicated, including sites over the neck, face, and chest, as these sites contain electrically sensitive structures. It is recommended that most patients increase the intensity to the maximum strength while still being comfortable to derive the most benefit from treatments.<xref ref-type="bibr" rid="article-30449.r2">[2]</xref></p>
      </sec>
      <sec id="article-30449.s7" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>It is imperative to read the manufacturer's instruction booklet, as each unit might have slight variances in recommendations. TENS units are now small and lightweight. Patients can place them in their pocket, on a desk, or hold them.&#x000a0;Treatment sessions occur at the patient's convenience except while operating heavy machinery, driving, bathing, showering, or swimming. The unit should&#x000a0;be powered&#x000a0;off before placing the pads. Electrode pad placement is at least 1 inch apart in the appropriate dermatomal region of the targeted pain. The skin underlying the pad placement must have an intact sensation. After powering the unit, the setting titration follows the&#x000a0;manufacturer's recommendations. Red and black lead placement have little impact on clinical outcomes.&#x000a0;</p>
      </sec>
      <sec id="article-30449.s8" sec-type="Complications">
        <title>Complications</title>
        <p>Despite its safety profile, there are cautions associated with TENS use.<xref ref-type="bibr" rid="article-30449.r16">[16]</xref>&#x000a0;Due to potential complications, individuals with pacemakers, epilepsy, or those in the throes of pregnancy are universally advised against TENS use. Theoretical risks extend to transdermal drug delivery systems and dermatologic concerns, urging a cautious approach.<xref ref-type="bibr" rid="article-30449.r15">[15]</xref> Steering clear of TENS during activities like driving or operating heavy machinery mitigates potential complications.</p>
      </sec>
      <sec id="article-30449.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>A&#x000a0;consensus on the efficacy of TENS in pain management has not been achieved, but the tapestry of positive outcomes is evident with prudent usage. Short-term triumphs demand strategic breaks and dynamic electrode pad placement. TENS seamlessly integrates into diverse clinical settings, necessitating formal pain assessments and crystal-clear instructions before initiation.</p>
        <p>TENS is not a cure for pain conditions or syndromes and should only be offered as a tool for symptomatic pain relief.<xref ref-type="bibr" rid="article-30449.r13">[13]</xref></p>
        <p>The&#x000a0;positive impact that TENS has on an individual might diminish&#x000a0;over time. Habituation might even lead to a worsening of pain. Recommendations are that patients take breaks from treatment, modulate between high frequency and low frequency within treatment sessions, increase the intensity of TENS daily, and vary their placement of electrode pads&#x000a0;over time.<xref ref-type="bibr" rid="article-30449.r10">[10]</xref></p>
        <p>Other methods of preventing analgesic tolerance include pharmacologic blockade of NMDA-glutamate receptors (such as ketamine or dextromethorphan) or CCK receptors in the spinal cord.<xref ref-type="bibr" rid="article-30449.r8">[8]</xref></p>
        <p>Regarding acute postoperative pain, efficacy is contingent upon investigators utilizing adequate TENS parameters and specific pain reduction outcomes. Adequate TENS parameters are defined by sufficient frequency and proper intensity. Adequate frequency is defined as 1 to 8 Hz for LF-TENS and 25 to 150 Hz for HF TENS, while adequate intensity is defined as solid sub-noxious, maximum tolerable, or &#x0003e;15 mA. If these parameters are strictly adhered to, then a significant reduction in postoperative opiate use (36%) is observed. Additionally, TENS is more effective in treating the pain associated with postoperative movements, such as walking or incentive spirometer use, but not in reducing pain at rest. Investigators have proposed that future trials should distinctly analyze movement pain from resting to assess the efficacy of TENS in treating&#x000a0;acute postoperative pain.<xref ref-type="bibr" rid="article-30449.r8">[8]</xref></p>
      </sec>
      <sec id="article-30449.s10" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>TENS emerges as a linchpin in various clinical domains, from hospice and palliative care to orthopedic surgery. However, before embarking on TENS treatment, a formal pain assessment led by seasoned professionals becomes paramount.<xref ref-type="bibr" rid="article-30449.r17">[17]</xref> Clear and understandable instructions pave the way, with monitored sessions guided by trained providers ensuring optimal understanding and utilization of TENS for pain management.<xref ref-type="bibr" rid="article-30449.r6">[6]</xref> The collaborative synergy of nurses, allied health professionals, and clinicians is pivotal, guaranteeing a comprehensive grasp of TENS's potential in pain management.</p>
      </sec>
      <sec id="article-30449.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30449&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30449">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30449/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30449">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-30449.s12">
        <fig id="article-30449.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Transcutaneous Electrical Nerve Stimulator Yeza, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-sa/4.0/">Public Domain</ext-link>, via&#x000a0;Wikimedia Commons&#x000a0;</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Tens" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-30449.s13">
        <title>References</title>
        <ref id="article-30449.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeSantana</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Vance</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rakel</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Sluka</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain.</article-title>
            <source>Curr Rheumatol Rep</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>492</fpage>
            <page-range>492-9</page-range>
            <pub-id pub-id-type="pmid">19007541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Transcutaneous Electrical Nerve Stimulation: Mechanisms, Clinical Application and Evidence.</article-title>
            <source>Rev Pain</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-11</page-range>
            <pub-id pub-id-type="pmid">26526976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chao</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Chao</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Chao</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>AMK</given-names>
              </name>
            </person-group>
            <article-title>Pain relief by applying transcutaneous electrical nerve stimulation (TENS) on acupuncture points during the first stage of labor: a randomized double-blind placebo-controlled trial.</article-title>
            <source>Pain</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>127</volume>
            <issue>3</issue>
            <fpage>214</fpage>
            <page-range>214-220</page-range>
            <pub-id pub-id-type="pmid">17030438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ainsworth</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Budelier</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Clinesmith</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fiedler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Landstrom</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Leeper</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Moeller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mutch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>O'Dell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Radhakrishnan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sluka</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Transcutaneous electrical nerve stimulation (TENS) reduces chronic hyperalgesia induced by muscle inflammation.</article-title>
            <source>Pain</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>120</volume>
            <issue>1-2</issue>
            <fpage>182</fpage>
            <page-range>182-187</page-range>
            <pub-id pub-id-type="pmid">16360266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liebano</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Rakel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vance</surname>
                <given-names>CGT</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Sluka</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>An investigation of the development of analgesic tolerance to TENS in humans.</article-title>
            <source>Pain</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>152</volume>
            <issue>2</issue>
            <fpage>335</fpage>
            <page-range>335-342</page-range>
            <pub-id pub-id-type="pmid">21144659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morgan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Mulcahy</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Finlay</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Collett</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Transcutaneous electric nerve stimulation (TENS) during distension shoulder arthrography: a controlled trial.</article-title>
            <source>Pain</source>
            <year>1996</year>
            <month>Feb</month>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>265</fpage>
            <page-range>265-267</page-range>
            <pub-id pub-id-type="pmid">8740603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Multimodal non-invasive non-pharmacological therapies for chronic pain: mechanisms and progress.</article-title>
            <source>BMC Med</source>
            <year>2023</year>
            <month>Sep</month>
            <day>29</day>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>372</fpage>
            <pub-id pub-id-type="pmid">37775758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vance</surname>
                <given-names>CGT</given-names>
              </name>
              <name>
                <surname>Dailey</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Chimenti</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Van Gorp</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Crofford</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Sluka</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Using TENS for Pain Control: Update on the State of the Evidence.</article-title>
            <source>Medicina (Kaunas)</source>
            <year>2022</year>
            <month>Sep</month>
            <day>22</day>
            <volume>58</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">36295493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gibson</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wand</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Meads</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Catley</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>O'Connell</surname>
                <given-names>NE</given-names>
              </name>
            </person-group>
            <article-title>Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2019</year>
            <month>Feb</month>
            <day>19</day>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>CD011890</fpage>
            <pub-id pub-id-type="pmid">30776855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vance</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Dailey</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Rakel</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Sluka</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Using TENS for pain control: the state of the evidence.</article-title>
            <source>Pain Manag</source>
            <year>2014</year>
            <month>May</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>197</fpage>
            <page-range>197-209</page-range>
            <pub-id pub-id-type="pmid">24953072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sluka</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bjordal</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Marchand</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rakel</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>What makes transcutaneous electrical nerve stimulation work? Making sense of the mixed results in the clinical literature.</article-title>
            <source>Phys Ther</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>93</volume>
            <issue>10</issue>
            <fpage>1397</fpage>
            <page-range>1397-402</page-range>
            <pub-id pub-id-type="pmid">23641031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Radhakrishnan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Dickman</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Herold</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Spurgin</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Sluka</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Spinal 5-HT(2) and 5-HT(3) receptors mediate low, but not high, frequency TENS-induced antihyperalgesia in rats.</article-title>
            <source>Pain</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>105</volume>
            <issue>1-2</issue>
            <fpage>205</fpage>
            <page-range>205-13</page-range>
            <pub-id pub-id-type="pmid">14499437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paley</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Wittkopf</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>MI</given-names>
              </name>
            </person-group>
            <article-title>Does TENS Reduce the Intensity of Acute and Chronic Pain? A Comprehensive Appraisal of the Characteristics and Outcomes of 169 Reviews and 49 Meta-Analyses.</article-title>
            <source>Medicina (Kaunas)</source>
            <year>2021</year>
            <month>Oct</month>
            <day>04</day>
            <volume>57</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">34684097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martimbianco</surname>
                <given-names>ALC</given-names>
              </name>
              <name>
                <surname>Porf&#x000ed;rio</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Pacheco</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Torloni</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Riera</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2019</year>
            <month>Dec</month>
            <day>12</day>
            <volume>12</volume>
            <issue>12</issue>
            <fpage>CD011927</fpage>
            <pub-id pub-id-type="pmid">31830313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sluka</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Vance</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Lisi</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>High-frequency, but not low-frequency, transcutaneous electrical nerve stimulation reduces aspartate and glutamate release in the spinal cord dorsal horn.</article-title>
            <source>J Neurochem</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>95</volume>
            <issue>6</issue>
            <fpage>1794</fpage>
            <page-range>1794-801</page-range>
            <pub-id pub-id-type="pmid">16236028</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Radhakrishnan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sluka</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Spinal muscarinic receptors are activated during low or high frequency TENS-induced antihyperalgesia in rats.</article-title>
            <source>Neuropharmacology</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>45</volume>
            <issue>8</issue>
            <fpage>1111</fpage>
            <page-range>1111-9</page-range>
            <pub-id pub-id-type="pmid">14614954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30449.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reeves</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Graff-Radford</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Shipman</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The effects of transcutaneous electrical nerve stimulation on experimental pain and sympathetic nervous system response.</article-title>
            <source>Pain Med</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>150</fpage>
            <page-range>150-61</page-range>
            <pub-id pub-id-type="pmid">15209969</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
